Orion 

$6.39
114
-$0.17-2.59% Today

Statistics

Day High
6.51
Day Low
6.34
52W High
12.84
52W Low
4.35
Volume
12,905
Avg. Volume
772,637
Mkt Cap
358.82M
P/E Ratio
19.63
Dividend Yield
1.26%
Dividend
0.08

Upcoming

Dividends

1.26%Dividend Yield
Apr 26
$0.02
Jan 26
$0.02
Oct 25
$0.02
Jul 25
$0.02
Apr 25
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.34
0.2
0.73
1.27
Expected EPS
0.06314
Actual EPS
N/A

Financials

-3.88%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.61BRevenue
-140.2MNet Income

Analyst Ratings

$5.58Average Price Target
The highest estimate is 6.50.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
33%
Sell
67%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OEC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap217.54B
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This competes directly with Orion's pharmaceutical products, especially in the diabetes and hormone replacement sectors.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical corporation which competes across various therapeutic areas including oncology, neurology, and immunology, overlapping with Orion's product portfolio.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is known for its contributions to pharmaceuticals across a range of conditions, directly competing with Orion in areas like cancer and neurodegenerative diseases.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca operates in key areas such as oncology, cardiovascular, renal & metabolism, and respiratory & immunology, which are also focus areas for Orion, making them direct competitors.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline is a global healthcare company that researches and develops a broad range of innovative products in pharmaceuticals, vaccines, and consumer healthcare, competing with Orion especially in the respiratory and CNS sectors.
Rogers
ROG
Mkt Cap1.57B
Roche Holding AG is a pioneer in healthcare, leading in cancer treatments and diagnostics, directly competing with Orion's oncology and diagnostic products.
Novartis
NVS
Mkt Cap237.61B
Novartis is one of the largest pharmaceutical companies by both market cap and sales, competing in areas like oncology, neurology, and immunology, similar to Orion.
Sanofi
SNY
Mkt Cap124.45B
Sanofi focuses on pharmaceuticals and human vaccines, with a strong presence in diabetes, oncology, and rare diseases, areas that Orion also operates in.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries Ltd. is a global leader in generic and specialty medicines, competing with Orion in the provision of generic drugs and active pharmaceutical ingredients.

About

Orion S.A., together with its subsidiaries, engages in the manufacture and sale of carbon black products. The company operates in two segments, Specialty Carbon Black and Rubber Carbon Black. It offers post-treated specialty carbon black grades for coatings and printing applications, as well as high purity carbon black grades for the fiber industry; and conductive carbon black grades for batteries, polymers, and coatings. The company also provides rubber carbon black products for tires, such as high-reinforcing grades and semi-reinforcing grades under the ECORAX brand, as well as for mechanical rubber goods end users, including automotive production, construction, as well as certain food, consumer, and medical applications. It operates in the United States, Brazil, rest of the Americas, Germany, South Africa, Italy, Spain, Turkey, France, Rest of EMEA, China, the Republic of Korea, and rest of Asia. The company was formerly known as Orion Engineered Carbons S.A. and changed its name to Orion S.A. in June 2023. Orion S.A. was founded in 1862 and is headquartered in Senningerberg, Luxembourg.
Show more...
CEO
Mr. Corning F. Painter
Employees
1658
Country
LU
ISIN
LU1092234845

Listings

0 Comments

Share your thoughts

FAQ

What is Orion stock price today?
The current price of OEC is $6.39 USD — it has decreased by -2.59% in the past 24 hours. Watch Orion stock price performance more closely on the chart.
What is Orion stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Orion stocks are traded under the ticker OEC.
Is Orion stock price growing?
OEC stock has risen by +3.51% compared to the previous week, the month change is a +20.45% rise, over the last year Orion has showed a -48.45% decrease.
What is Orion market cap?
Today Orion has the market capitalization of 358.82M
When is the next Orion earnings date?
Orion is going to release the next earnings report on April 30, 2026.
What were Orion earnings last quarter?
OEC earnings for the last quarter are -0.34 USD per share, whereas the estimation was -0.07 USD resulting in a -386.61% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Orion revenue for the last year?
Orion revenue for the last year amounts to 3.61B USD.
What is Orion net income for the last year?
OEC net income for the last year is -140.2M USD.
Does Orion pay dividends?
Yes, OEC dividends are paid quarterly. The last dividend per share was 0.02 USD. As of today, Dividend Yield (FWD)% is 1.26%.
How many employees does Orion have?
As of April 02, 2026, the company has 1,658 employees.
In which sector is Orion located?
Orion operates in the Materials sector.
When did Orion complete a stock split?
Orion has not had any recent stock splits.
Where is Orion headquartered?
Orion is headquartered in Senningerberg, LU.